Electromed, Inc. (ELMD) intrinsic value & 10-year financials

Electromed, Inc. (ELMD) has a Graham intrinsic value of $26.17 per share. At $27.42 on Oct 17, 2026, the stock trades 5% above that value. Over the last 10 fiscal years revenue grew 12.1% a year to $64.0M, with an average return on invested capital of 13.9%.

Graham intrinsic value
$26.17
Share price (Oct 17, 2026)
$27.42
Price vs Graham value
5% above
Market cap
$244.4M
Revenue (FY2025)
$64.0M
Revenue growth (10-yr CAGR)
12.1%
ROIC (10-yr avg)
13.9%
Free cash flow (FY2025)
$11.1M

ELMD 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $64.0M $7.5M $0.85 $11.1M 15.1% 16.1%
FY2024 $54.7M $5.2M $0.58 $8.8M 12.0% 11.7%
FY2023 $48.1M $3.2M $0.36 -$333.0K 8.3% 8.6%
FY2022 $41.7M $2.3M $0.26 -$2.1M 7.1% 11.1%
FY2021 $35.8M $2.4M $0.27 $2.8M 8.8% 11.6%
FY2020 $32.5M $4.2M $0.47 $3.4M 15.8% 21.5%
FY2019 $31.3M $2.0M $0.23 $1.3M 9.0% 11.4%
FY2018 $28.3M $1.9M $0.22 $1.9M 10.6% 12.5%
FY2017 $25.9M $2.2M $0.26 $572.4K 13.8% 16.7%
FY2016 $23.0M $2.2M $0.27 $1.6M 13.5% 18.2%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Electromed, Inc. is a consistent compounder, expanding top-line revenue at 12.0% annually over the past decade.

Electromed, Inc. returns on capital have been average, hovering around 14.0% ROIC over the decade.

Electromed, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Electromed, Inc. is modeled at 13.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $26.17 per share.

ELMD stock: frequently asked questions

What is the intrinsic value of Electromed, Inc. (ELMD) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 13.6% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, ELMD's intrinsic value is about $26.17 per share.

Is ELMD stock undervalued?

At $27.42 (close on Oct 17, 2026), ELMD trades 5% above its Graham value of $26.17. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Electromed, Inc. grown?

Revenue went from $23.0M in fiscal 2016 to $64.0M in fiscal 2025, a compound annual growth rate of 12.1%. Net income was $7.5M in fiscal 2025.

Does Electromed, Inc. generate free cash flow?

Electromed, Inc. generated $11.1M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 8 of the last 10 reported years.

What is ELMD's return on invested capital?

Average ROIC over the last 10 fiscal years was 13.9%, and average return on equity was 11.2%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ELMD data come from?

From Electromed, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 12, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar electromedical & electrotherapeutic apparatus stocks